Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aziyo Biologics, Inc. (AZYO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
6.40-0.27 (-4.05%)
At close: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/23/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 318.20
52 Week Low 34.10
50-Day Moving Average 35.97
200-Day Moving Average 38.24

Share Statistics

Avg Vol (3 month) 316.15k
Avg Vol (10 day) 34.09k
Shares Outstanding 59.25M
Implied Shares Outstanding 6N/A
Float 81.36M
% Held by Insiders 19.61%
% Held by Institutions 1114.95%
Shares Short (Dec 30, 2021) 41.81k
Short Ratio (Dec 30, 2021) 40.07
Short % of Float (Dec 30, 2021) 40.02%
Short % of Shares Outstanding (Dec 30, 2021) 40.01%
Shares Short (prior month Nov 29, 2021) 48.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin -43.12%
Operating Margin (ttm)-37.62%

Management Effectiveness

Return on Assets (ttm)-21.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)48.99M
Revenue Per Share (ttm)4.88
Quarterly Revenue Growth (yoy)-2.50%
Gross Profit (ttm)20.56M
EBITDA -14.69M
Net Income Avi to Common (ttm)-21.12M
Diluted EPS (ttm)-2.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.54M
Total Cash Per Share (mrq)2.2
Total Debt (mrq)22.06M
Total Debt/Equity (mrq)280.71
Current Ratio (mrq)1.74
Book Value Per Share (mrq)0.77

Cash Flow Statement

Operating Cash Flow (ttm)-14.43M
Levered Free Cash Flow (ttm)-8.73M
Advertisement
Advertisement